Westfalia-Automotive achieves debt forgiveness and release from all First Brands Group related claims
1.6.2026 15:57:14 CEST | news aktuell GmbH | Press release
Rheda-Wiedenbrück, Germany – After successfully separating from First Brands Group in March 2026, Westfalia Automotive Group has completed a transaction resulting in debt forgiveness for group entities in the amount of approximately USD 246 million, as well as a release from all First Brands related claims.
"This transaction creates a debt-free operating group and significantly strengthens the underlying balance sheets of Westfalia — another significant milestone. With a focus on expanding production and customer care, the business is well positioned for continued growth. As the primary 'made in Europe' towing brand, we are committed to the customers and partners who have made us a market leader, and our entire team is energized to build on that foundation." — Michael Scott, Board Member, Westfalia-Automotive Group
“Westfalia-Automotive enters this next chapter from a position of strength. A competitive brand is built on strong partnerships with our customers, and we are fully committed to delivering on an exciting pipeline of new products. Our teams and operational sites in Germany, France, Romania and India are ready to build, deliver, and grow, ensuring we meet the diverse needs of our partners in the automotive industry.” — Tomasz Sgaslik, Managing Director, Westfalia-Automotive Group
About Westfalia-Automotive Group
Westfalia-Automotive is the European market leader and one of the world's leading manufacturers of towbars and bike racks for cars and light commercial vehicles.
The company serves automotive original equipment manufacturers (OEMs), wholesalers, and dealer networks as the category leader in the automotive and leisure segments. Westfalia-Automotive provides its customers with outstanding products and services that reflect the company’s commitment to market leadership, innovation, and operational excellence.
The Company’s mission is to utilize forward-thinking technology to develop and deliver premium products for customers, engage with employees, and create value for shareholders.
Westfalia-Automotive is home to some of Europe’s most recognized brands in the towing industry, including: Westfalia-Automotive, Siarr, Witter-Towbars and others.
About news aktuell GmbH
news aktuell, a subsidiary of the Deutsche Presse-Agentur (dpa), provides companies, institutions and associations with effective access to both the media and consumers and supports the organizations in telling their stories easily and successfully. Utilizing the digital tools “ots” and “zimpel” PR content reaches all media formats, including classic print titles, wide-reach online portals or social networks. In addition, news aktuell publishes all of its clients' PR content on www.presseportal.de, one of Germany's widest-reaching PR portals. Thus, all relevant multipliers are reached worldwide, ranging from editors and digital influencers to specialist bloggers and interested consumers. Communications specialists from all over Germany rely on the expertise of the dpa subsidiary. news aktuell has been on the market since 1989 and employs over 135 people. The company is based in Hamburg. Further locations include Berlin, Frankfurt and Munich.
Subscribe to releases from news aktuell GmbH
Subscribe to all the latest releases from news aktuell GmbH by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from news aktuell GmbH
Grünenthal strengthens its Genetic Medicine Capabilities and joins the Cluster for Nucleic Acid Therapeutics Munich16.7.2026 10:42:31 CEST | Press release
Aachen, Germany, 16 July 2026 – Grünenthal announced today that the company has joined the Cluster for Nucleic Acid Therapeutics Munich (CNATM), a Munich-centred innovation network that brings together leading universities, research institutions, biotech companies and industry partners to accelerate next-generation nucleic acid therapeutics into innovative treatments that can make a meaningful difference for patients
They’re really going for it: emporia launches the first 5G smartphone with a screen warranty15.7.2026 08:40:22 CEST | Press release
Better safe than sorry: the emporiaSMART.8 with Smartcover and rubber protectors
FEV collaborates with Microsoft on efficient AI model approach for in car applications built on NVIDIA9.7.2026 11:05:00 CEST | Press release
Aachen – FEV is collaborating with Microsoft to integrate powerful, in-vehicle Generative AI capabilities built on NVIDIA GPU-accelerated compute and AI model microservices. The cooperation aims to enable multimodal voice, text, and gesture interactions directly in the vehicle – independent of a permanent Internet connection.
Acrobat Studio og Acrobat KI-assistent: den nye generasjonen KI-støttet produktivitet – nå også på norsk8.7.2026 15:08:48 CEST | Press release
SAN JOSE, Calif. - 8. juli 2026 - Adobe utvider tilgjengeligheten til Acrobat Studio og Acrobat KI-assistenten i Norge. Nå er de KI-støttede funksjonene for produktivitet og kreavtivitet også tilgjengelige på norsk, og kan dermed brukes av brukere på lokalt språk. Acrobat Studio kombinerer Adobe Acrobat Pro, Adobe Express Premium og smarte KI-assistenter. Acrobat KI-assistent er også tilgjengelig som et separat tillegg for alle Adobe Acrobat-produkter (Acrobat Reader, Acrobat Standard og Acrobat Pro) – et fleksibelt alternativ for alle som ønsker å bruke KI-støttede funksjoner kun når de arbeider med dokumenter. Begge disse tilbudene gjør det mulig for brukere å raskere samle inn informasjon i PDF-er og Office-dokumenter, opprette innhold og effektivisere arbeidsflyten. Acrobat Studio og Acrobat KI-assistenten markerer et viktig trinn i utviklingen av PDF-filen, som har blitt standarden for viktige dokumenter siden den ble lansert av Adobe i 1993. Acrobat utvikler seg fra et ledende pr
Grünenthal receives FDA Orphan Drug and Rare Pediatric Disease Designations for Tegacorat for the Treatment of Duchenne Muscular Dystrophy8.7.2026 10:37:04 CEST | Press release
Aachen, 08 July 2026 – Grünenthal announced today that its investigational compound tegacorat (GRM-01) received Orphan Drug and Rare Pediatric Disease Designations from the US Food and Drug Administration (FDA) for the treatment of Duchenne muscular dystrophy (DMD).
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom